Alumni raised $1.45B in 2022 - Download Free Report Now

SARcode Bioscience (Acquired)

Novel molecules to target chronic T-cell mediated inflammatory diseases.

Start Free Trial
Claim Company Profile

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of SARcode Bioscience (Acquired) plus 5517 other startups.

Start Free 7 Day Trial Now

Learn More About SARcode Bioscience (Acquired)

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

Competing Startups

More

Companies We Work With

  • 0-Minnetronix.jpg
  • 1-jnj.png
  • 2-medtronic.png
  • 3-abbott.png
  • 4-baxter.png
  • 7-bostonscientific.png
  • 8-bd.png
  • 9-smithnephew.png
  • 10-stryker.png
  • 33m.png
  • allergan.jpg
  • bain.jpg
  • bbraun.png
  • beckmancoulter.png
  • cardinal.png
  • depuysynthes.png
  • drager.png
  • edwardslifesciences.png
  • ethicon.png
  • ge.png
  • gore.png
  • hospira.png
  • jlabs.jpg
  • kimberlyclark.png
  • merck.jpg
  • olympus.png
  • orthofix.png
  • philips.png
  • sanofigenzyme.png
  • teleflex.jpg
  • terumo.png
  • zimmerbiomet.png